Skip to main content
Equibles

James Topper

Board Member

Phathom Pharmaceuticals, Inc. (PHAT)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About James Topper

James Topper is recorded as Board Member at Phathom Pharmaceuticals, Inc. (PHAT). Earlier roles on record: Chairman and Board Member at Anaptysbio, Inc (ANAB) until September 15, 2023. Anaptysbio, Inc reported in an 8-K filed September 18, 2023 that James Topper resigned as Class II director, effective September 15, 2023. Anaptysbio, Inc reported in an 8-K filed September 18, 2023 that James Topper resigned as Chairman of the Board, effective September 15, 2023.

“On September 14, 2023, James N. Topper, M.D., Ph.D., advised the Board of Directors (the "Board") of AnaptysBio, Inc. (the "Company") that he would resign as a Class II director and as Chairman of the Board, effective on September 15, 2023.”
Anaptysbio, Inc Form 8-K, filed September 18, 2023 · Read the filing
“On September 14, 2023, James N. Topper, M.D., Ph.D., advised the Board of Directors (the "Board") of AnaptysBio, Inc. (the "Company") that he would resign as a Class II director and as Chairman of the Board, effective on September 15, 2023.”
Anaptysbio, Inc Form 8-K, filed September 18, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Phathom Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.